A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
Clinical trial NCT07765537 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07765537
- Sponsor
- Shenzhen Fosun Kairos Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-09-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.